SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Idorsia Seeks US Label Update for QUVIVIQ Benefits

Idorsia seeks a US label update for QUVIVIQ concerning daytime functioning benefits. The headline also reports that first patients have enrolled in Dari-Dream, but the text does not identify the study or enrollment details.

Related stories